Novadip Biosciences SA raises €40m
Wth a Series B €40m financing, Novadip Biosciences SA has raised investements to a total of €88m. It will use the proceeds to push two single-use cell therapies designed to accelerate healing.
ADVERTISEMENT
About Margarita Milidakis
This author has not written his bio yet.
But we are proud to say that Margarita Milidakis contributed 42 entries already.
Entries by Margarita Milidakis
Benefits of booster campaigns questionable
Three small-scale studies hinted at new COVID-19 vaccination boosters not significantly enhancing the immune response to Omicron variant.